FCMI
Foresite Capital Management I Portfolio holdings
AUM
$21.4M
This Quarter Return
+26.25%
1 Year Return
-80.48%
3 Year Return
-40.72%
5 Year Return
–
10 Year Return
–
AUM
$119M
AUM Growth
+$119M
(-16%)
Cap. Flow
-$42.4M
Cap. Flow
% of AUM
-35.54%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
–
Increased
1
Reduced
3
Closed
2
Top Buys
| 1 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$1.18M |
Top Sells
| 1 |
KERX
Keryx Biopharmaceuticals Inc
KERX
|
$22.4M |
| 2 |
Karyopharm Therapeutics
KPTI
|
$9.7M |
| 3 |
Novavax
NVAX
|
$6.05M |
| 4 |
Talphera
TLPH
|
$5.44M |
| 5 |
Xencor
XNCR
|
$31.4K |
Sector Composition
| 1 | Healthcare | 87.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Karyopharm Therapeutics
KPTI
$61.7M
| $64.1M | 53.75% | 1,377,410 -208,333 | -13% | -$9.7M |
|
|
AMBI
2
DELISTED
AMBIT BIOSCIENCES CORP COM STK (DE)
AMBI
| $14.4M | 12.05% | 2,079,569 | – | – |
|
|
3
Xencor
XNCR
$580M
| $9.5M | 7.96% | 817,300 -2,700 | -0.3% | -$31.4K |
|
|
4
Talphera
TLPH
$11.1M
| $8.69M | 7.29% | 847,983 -531,097 | -39% | -$5.44M |
|
|
BDSI
5
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $8.45M | 7.08% | 700,000 | – | – |
|
|
OREX
6
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $7.73M | 6.48% | 1,250,000 | – | – |
|
|
RXDX
7
DELISTED
Ignyta, Inc.
RXDX
| $4.55M | 3.81% | 500,000 | – | – |
|
|
XLRN
8
DELISTED
Acceleron Pharma Inc.
XLRN
| $1.89M | 1.59% | 55,767 +34,875 | +167% | +$1.18M |
|
|
9
Novavax
NVAX
$1.21B
| – | – | -1,336,200 | Closed | -$6.05M |
|
|
KERX
10
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| – | – | -1,312,006 | Closed | -$22.4M |
|